Vivo Bio Tech Limited is conducting a postal ballot and e-voting to seek shareholder approval for several key proposals. Shareholders will vote on the re-appointment of Mr. Shyam Sunder Singh and Mr. Anand Goutham Chand Jain as Independent Directors for a second consecutive term of five years. Additionally, the company is seeking approval to increase the maximum number of Independent Directors on its board from six to eight. These resolutions are important for the company's governance structure and maintaining board stability.